View in EDS HTML Full Text PDF Full Text

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.

Saved in:
Bibliographic Details
Title: Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.
Authors: Ibrahim D; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Grondin M; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Galpin K; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Asif S; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Thompson E; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Nersesian S; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Abou-Hamad J; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Echaibi M; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Rodriguez GM; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Navals P; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Macdonald E; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Ryan B; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Cook DP; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Keillor JW; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Vanderhyden BC; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Source: Frontiers in immunology [Front Immunol] 2025 Jul 24; Vol. 16, pp. 1639853. Date of Electronic Publication: 2025 Jul 24 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40777010
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ibrahim+D%22">Ibrahim D</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Grondin+M%22">Grondin M</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Galpin+K%22">Galpin K</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Asif+S%22">Asif S</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Thompson+E%22">Thompson E</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Nersesian+S%22">Nersesian S</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Abou-Hamad+J%22">Abou-Hamad J</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Echaibi+M%22">Echaibi M</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Rodriguez+GM%22">Rodriguez GM</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Navals+P%22">Navals P</searchLink>; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Macdonald+E%22">Macdonald E</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Ryan+B%22">Ryan B</searchLink>; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Cook+DP%22">Cook DP</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Keillor+JW%22">Keillor JW</searchLink>; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Vanderhyden+BC%22">Vanderhyden BC</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Jul 24; Vol. 16, pp. 1639853. <i>Date of Electronic Publication: </i>2025 Jul 24 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40777010
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1639853
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1639853
    Titles:
      – TitleFull: Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ibrahim D
      – PersonEntity:
          Name:
            NameFull: Grondin M
      – PersonEntity:
          Name:
            NameFull: Galpin K
      – PersonEntity:
          Name:
            NameFull: Asif S
      – PersonEntity:
          Name:
            NameFull: Thompson E
      – PersonEntity:
          Name:
            NameFull: Nersesian S
      – PersonEntity:
          Name:
            NameFull: Abou-Hamad J
      – PersonEntity:
          Name:
            NameFull: Echaibi M
      – PersonEntity:
          Name:
            NameFull: Rodriguez GM
      – PersonEntity:
          Name:
            NameFull: Navals P
      – PersonEntity:
          Name:
            NameFull: Macdonald E
      – PersonEntity:
          Name:
            NameFull: Ryan B
      – PersonEntity:
          Name:
            NameFull: Cook DP
      – PersonEntity:
          Name:
            NameFull: Keillor JW
      – PersonEntity:
          Name:
            NameFull: Vanderhyden BC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 07
              Text: 2025 Jul 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1